These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 623110)
21. Economic consequences of the maximum allowable cost program to the entire profession of pharmacy. Paul SH Med Mark Media; 1979 Aug; 14(8):19-26. PubMed ID: 10243270 [No Abstract] [Full Text] [Related]
22. Involvement of a state society of hospital pharmacists in third-party reimbursement for nondistributive services. Breland BD; Hayman JN Am J Hosp Pharm; 1982 Nov; 39(11):1937-9. PubMed ID: 7148865 [TBL] [Abstract][Full Text] [Related]
23. Economics of institutional pharmacy services under national health insurance in Australia. Brooks GE; Knapp DA Am J Hosp Pharm; 1975 Oct; 32(10):1018-22. PubMed ID: 1190213 [TBL] [Abstract][Full Text] [Related]
33. Estimating a reasonable reimbursement for community pharmacies in third-party programs. Carroll NV Manag Care Interface; 1999 Feb; 12(2):73-6, 79-80. PubMed ID: 10346189 [TBL] [Abstract][Full Text] [Related]
34. Health Care Financing Administration: Pharmaceutical Reimbursement Board; final maximum allowable cost determinations. Fed Regist; 1979 Aug; 44(169):50651-6. PubMed ID: 10297564 [No Abstract] [Full Text] [Related]
35. The hospital-based preferred provider organization and its potential impact on hospital pharmacy. Larson LN; Messier DR Hosp Pharm; 1986 Mar; 21(3):245-6. PubMed ID: 10275585 [TBL] [Abstract][Full Text] [Related]
36. Health Services Administration--Maternal and child health/crippled children's service program; policy statement on third-party reimbursement for services to mothers and children. General notice. Fed Regist; 1980 Jul; 45(130):45337. PubMed ID: 10317017 [TBL] [Abstract][Full Text] [Related]
37. 1976 third-party reimbursement experience: an interstate comparison by insurance carrier. Dörken H; Webb JT Am Psychol; 1980 Apr; 35(4):355-63. PubMed ID: 7386967 [No Abstract] [Full Text] [Related]
38. Reimbursement for clinical services. Patel N; Murdico AT Am J Health Syst Pharm; 2007 May; 64(9):926. PubMed ID: 17468146 [No Abstract] [Full Text] [Related]
39. Reimbursement for clinical pharmaceutical services in university hospitals. Sylvester KL Am J Hosp Pharm; 1982 Apr; 39(4):642-3. PubMed ID: 7081242 [No Abstract] [Full Text] [Related]
40. Pharmacoeconomic considerations in rural hospitals. Lenhert P Cost Qual Q J; 1998 Jun; 4(2):37-42. PubMed ID: 10182598 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]